Cannabis Stock Gainers And Losers From November 15, 2023
GAINERS: EVIO (OTC:EVIO) shares closed up 9900.00% at $0.0001 MPX International (OTC:MPXOF) shares closed up 9900.00% at $0.0001…
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ: CMPS) for Treatment-Resistant Depression and Awakn Life Sciences (OTCMKTS: AWKNF) for Severe Alcohol Use Disorder (SAUD).
Detroit Issues 37 Cannabis Retail Licenses & First Consumption Lounge Is Approved
Detroit Michigan's cannabis authorities have granted licenses to 37 entrepreneurs for recreational marijuana businesses, including dispensaries and the city's first consumption lounge,
Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals
Clinical-stage psychedelics biotech Cybin Inc. (NYSE: CYBN) released its financial results for second quarter ended September 30, 2023.
California Weed Co. Settles Debt And Celebrates Turn-Around In Q3
Unrivaled Brands, Inc. (OTCQB: UNRV) reported its third quarter financial results Tuesday for the three months ended Sept. 30, 2023, revealing an 11.4% year-over-year drop in revenue to $8.6 million.
Sativa Or Indica? Canopy Growth Launches New Cannabis Flower Products To Suit All Tastes
Canopy Growth Corp. (TSX: WEED) (NASDAQ: CGC) reported on Wednesday that it has added four new flower product offerings from iconic brands 7ACRES and Tweed.
Defying Cannabis Market Challenges: Canadian Pot Producer Reports YoY Revenue Growth
Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) reported its third quarter financial results on Tuesday for the three months ended Sept. 30, 2023, revealing a 5% year-over-year increase in revenue to CA$10 million ($7.26 million).
U.S. Cannabis: Growth At A Reasonable Price?
By Todd Harrison via Cannabis Confidential (Nov 14)
Strong Margins And Cash Flow Drive Cresco’s Q3 Performance Despite Revenue Decline
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) released its financial and operating results on Wednesday for the third quarter ended Sept. 30, 2023, revealing a 9.4% year-over-year decrease in revenue to $190.5 million.
East Coast Drives Growth For This Cannabis Company, Narrows Q3 Net Loss By Nearly 70% YoY
Acreage Holdings, Inc. (CSE: ACRG.A.U) (ACRG.B.U) (OTCQX: ACRDF) reported its financial results Tuesday for the third quarter ended Sept. 30, 2023, revealing consolidated revenue of $56.5 million, an 8% year-over-year and 2.8% quarter-over-quarter decrease.